Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 2Phase NA 1Phase 1/2 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 161Neoplasms 95Prostatic Neoplasms 86Glioblastoma 76Multiple Myeloma 65Pancreatic Neoplasms 64Glioma 61Brain Neoplasms 56Lung Neoplasms 46Carcinoma, Hepatocellular 45Melanoma 43Head and Neck Neoplasms 43Recurrence 42Carcinoma, Non-Small-Cell Lung 41Leukemia, Myeloid, Acute 40Colorectal Neoplasms 39Squamous Cell Carcinoma of Head and Neck 35Ovarian Neoplasms 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 29Lymphoma 28Carcinoma, Renal Cell 28Polycystic Ovary Syndrome 27Stomach Neoplasms 24Hematologic Neoplasms 23Lymphoma, B-Cell 22Sarcoma 21Endometrial Neoplasms 20Uterine Cervical Neoplasms 19

Interventions

daratumumab 1Simvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Hemangioma, Cavernous, Central Nervous System × Clear all
NCT07026604 2025-06-18

CCM-DS01

Beijing Tiantan Hospital

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

NCT01764451 2024-03-12

Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

University of New Mexico

Phase EARLY_PHASE1 Terminated
12 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡